Artivion Quarterly Cash Flow Statement
NYSE: AORTHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Artivion free cash flow
In the quarter ended Jun 30, 2026, Artivion generated -$1.3 million of operating cash flow and spent $10.7 million on capital expenditures. That left free cash flow of -$12.0 million, a free-cash-flow margin of -9.6% of revenue. Free cash flow was down 202.5% from the prior year's $11.7 million.
Summary generated from market data by MetaCap's automated system. Methodology
Artivion cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -13.51M | 1.42M | 2.43M | 6.50M | 1.34M | -505.00K | -16.48M | -2.29M | -2.12M | 7.53M | -3.98M | -9.80M |
| Net Income growth (YoY) | -1104.46% | — | — | — | — | -106.70% | — | — | — | — | -283.26% | — |
| Depreciation & Amortization | 6.75M | 6.34M | 5.76M | 5.72M | 5.54M | 5.45M | 6.29M | 6.11M | 5.89M | 5.91M | 5.82M | 5.76M |
| Stock-Based Compensation | 8.16M | 8.41M | 4.08M | 6.13M | 6.12M | 8.04M | 2.74M | 3.77M | 4.25M | 3.48M | 3.96M | 3.19M |
| Change in Working Capital | -4.86M | -12.75M | 5.94M | 9.28M | 2.20M | -24.30M | 2.25M | 4.35M | -2.88M | -14.82M | 330.00K | 705.00K |
| Operating Cash Flow | -1.27M | 1.15M | 19.56M | 22.26M | 15.01M | -16.95M | 10.14M | 11.46M | 6.13M | -5.49M | 10.84M | 7.23M |
| Capital Expenditures | -10.75M | -8.00M | -27.51M | -4.61M | -3.29M | -3.64M | -1.43M | -3.64M | -2.51M | -3.61M | -2.67M | -2.07M |
| Investing Cash Flow | -129.41M | -10.50M | -30.51M | -4.61M | -3.29M | -3.64M | -11.43M | -10.64M | -2.51M | -3.61M | -2.67M | -2.07M |
| Debt Issued | — | — | 0 | 0 | 0 | 0 | -6.00M | 0 | 0 | 190.00M | 0 | 0 |
| Debt Repaid | 0 | 0 | -3.00K | -73.00K | -68.00K | -66.00K | -66.00K | -77.00K | -61.00K | -211.63M | -709.00K | -682.00K |
| Financing Cash Flow | 152.39M | 463.00K | 2.43M | 2.32M | 2.60M | 3.94M | 174.00K | 1.47M | -181.00K | 737.00K | -1.63M | -909.00K |
| Net Change in Cash | 21.55M | -9.14M | -8.52M | 19.95M | 15.78M | -15.77M | -2.71M | 1.15M | 3.90M | -7.82M | 5.46M | 4.71M |
| Free Cash Flow | -12.01M | -6.85M | -7.95M | 17.65M | 11.72M | -20.59M | 8.71M | 7.82M | 3.62M | -9.10M | 8.17M | 5.16M |
This table shows 12 quarterly periods of Artivion's cash flow statement, from Q2 2026 back to Q3 2023, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow AORT's reporting calendar. What is a cash flow statement?